ICL Group Ltd. ICL

Healthcare SIC 2870 - Agricultural Chemicals NAICS Manufacturing › Chemical Manufacturing › Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing › Fertilizer and Compost Manufacturing derived NYSE

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $7.15B$6.84B$7.54B$10.02B$6.96B$5.04B$5.27B$5.56B$5.42B$5.36B
Operating income $580.0M$775.0M$1.14B$3.52B$1.21B$202.0M$756.0M$1.52B$629.0M-$3.0M
Net income $280.0M$464.0M$687.0M$2.22B$832.0M$24.0M$481.0M$1.24B$347.0M-$172.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets $12.41B$11.32B$11.63B$11.75B$11.08B$9.66B$9.17B$8.78B$8.71B$8.55B
Total equity $6.24B$5.99B$6.04B$5.71B$4.74B$4.09B$4.06B$3.92B$2.93B$2.66B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001178913-26-000817.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B 0 5B 10B 15B Revenue, FY2016: 5.4B Net income, FY2016: -172M Revenue, FY2017: 5.4B Net income, FY2017: 347M Revenue, FY2018: 5.6B Net income, FY2018: 1.2B Revenue, FY2019: 5.3B Net income, FY2019: 481M Revenue, FY2020: 5B Net income, FY2020: 24M Revenue, FY2021: 7B Net income, FY2021: 832M Revenue, FY2022: 10B Net income, FY2022: 2.2B Revenue, FY2023: 7.5B Net income, FY2023: 687M Revenue, FY2024: 6.8B Net income, FY2024: 464M Revenue, FY2025: 7.2B Net income, FY2025: 280M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $5.36B $5.42B $5.56B $5.27B $5.04B $6.96B $10.02B $7.54B $6.84B $7.15B
Gross profit — — — — — — — — — —
Net income -$172.0M $347.0M $1.24B $481.0M $24.0M $832.0M $2.22B $687.0M $464.0M $280.0M

Others in SIC 2870

TickerCompanyMarket capP/ERevenue growth
CF CF Industries Holdings, Inc. $18.26B 13.5x 19.3%
MOS MOSAIC CO $5.67B 10.5x 8.4%
SMG SCOTTS MIRACLE-GRO CO $3.45B 24.0x -3.9%
UAN CVR PARTNERS, LP $1.33B 13.4x 15.4%
CBUS Cibus, Inc. $108.2M — -14.6%
AVD AMERICAN VANGUARD CORP $30.4M — -5.9%
SNES SenesTech, Inc. $4.6M — 19.6%
BIOX Bioceres Crop Solutions Corp. — — -27.9%